Last reviewed: September 3, 2026 Last updated: September 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Embody publishes standard ongoing rates for injectable semaglutide ($299 month-to-month) and tirzepatide ($349 month-to-month), offers unlimited provider visits and 24/7 clinical chat, and backs treatment with a 6-month satisfaction guarantee. BetterMe Rx discloses pricing only after completing an online questionnaire; as of July 2026 no verified pricing, medication formats, billing structure, clinical support details, or refund terms have been documented in public sources or through checkout verification.

If transparent published pricing and documented clinical support matter to your decision process, Embody provides complete commercial information. If you are comfortable completing an intake to learn costs and terms, BetterMe Rx may offer a structure suited to your needs—though you will not know pricing, commitment requirements, or included services until after you begin the application.

Comparing multiple GLP-1 programs?

Review published rates, clinical support, and medication options across platforms.

See all weight-management options →

At a glance: Embody vs BetterMe Rx

Feature Embody BetterMe Rx PlexusDx
Semaglutide injection (MTM) $299/month Not published $189/month
Tirzepatide injection (MTM) $349/month Not published $289/month
Oral/capsule formats Not documented Not documented Semaglutide $289 MTM, Tirzepatide $349 MTM
Committed-term rates Not published per methodology Unknown 3-month and 6-month prepaid available
Billing cadence Month-to-month Not documented Month-to-month, 3-month, 6-month
Membership fee None Not documented None
Clinical support Unlimited provider visits, 24/7 clinical chat Not documented Unlimited messaging, scheduled visits
Money-back guarantee 6-month satisfaction guarantee Not documented None
Charge timing After prescription and dose approval Not documented After provider approval
Evidence date July 21, 2026 July 20, 2026 Current

Source notes: Embody pricing and terms from public website capture July 21, 2026. BetterMe Rx shows "pricing after questionnaire" per website capture July 20, 2026; no checkout verification completed as of evidence date. PlexusDx rates are current standard published rates.

Normalized 12-month costs

To compare programs with different billing structures, we calculate total cost over 12 months using only standard ongoing rates. All calculations below are ours unless otherwise noted.

Semaglutide injection

  • Embody month-to-month: $299/month × 12 = $3,588 annual (our calculation)
  • BetterMe Rx: No pricing data available; cannot calculate
  • PlexusDx month-to-month: $189/month × 12 = $2,268 annual (our calculation)
  • PlexusDx 3-month prepaid: $169/month equivalent × 12 = $2,028 annual (our calculation from $507 prepaid total × 4 periods)
  • PlexusDx 6-month prepaid: $149/month equivalent × 12 = $1,788 annual (our calculation from $894 prepaid total × 2 periods)

Tirzepatide injection

  • Embody month-to-month: $349/month × 12 = $4,188 annual (our calculation)
  • BetterMe Rx: No pricing data available; cannot calculate
  • PlexusDx month-to-month: $289/month × 12 = $3,468 annual (our calculation)
  • PlexusDx 3-month prepaid: $269/month equivalent × 12 = $3,228 annual (our calculation from $807 prepaid total × 4 periods)
  • PlexusDx 6-month prepaid: $249/month equivalent × 12 = $2,988 annual (our calculation from $1,494 prepaid total × 2 periods)

Embody's evidence base documents month-to-month pricing only; any lower committed-term rates are withheld per our methodology (see below). BetterMe Rx discloses no pricing publicly, so no calculation is possible until you complete intake.

PlexusDx semaglutide injection: $189 month-to-month, $1,788 annual at 6-month rate

A licensed provider reviews your intake and determines whether a prescription is appropriate.

Start My 60-Second Intake →

About 60 seconds · $0 charged until provider approval.

Evidence strengths and gaps

What the evidence documents clearly

Embody: Standard month-to-month rates for both semaglutide and tirzepatide injections are published and verified. The program includes unlimited provider visits and 24/7 clinical chat at no additional charge, operates on cancel-anytime monthly billing, and offers a 6-month satisfaction guarantee (full terms of the guarantee were not captured). Same price applies at every dose. No charge until prescription and dose are approved.

BetterMe Rx: The website states pricing is shown after completing a questionnaire. As of July 20, 2026 no public pricing, medication availability, billing cadence, fee structure, clinical support details, or refund terms have been captured or verified through checkout.

PlexusDx: Month-to-month, 3-month prepaid, and 6-month prepaid rates published for injectable semaglutide and tirzepatide, plus oral/capsule formats. No membership fee. Unlimited messaging and scheduled provider visits included. Evidence is current.

What remains uncertain

Embody: Whether lower committed-term rates exist (such data is withheld per our methodology). Whether oral or capsule formats are available. Full details of the 6-month money-back guarantee, including eligibility criteria and claim process.

BetterMe Rx: All commercial terms—pricing, medication formats, billing structure, clinical inclusions, cancellation/refund policy—remain unknown until intake is completed. Whether pricing varies by medication, dose, or commitment length is undocumented.

Decision factors

Published transparency vs. intake-gated pricing

Embody and PlexusDx both publish standard rates publicly; you know cost before beginning an application. BetterMe Rx requires completing a questionnaire to learn pricing. If you prefer to evaluate cost and terms before sharing health information, published-price models offer that option. If you are comfortable with intake-first disclosure, BetterMe Rx may suit your workflow—though you accept that pricing, commitment requirements, and included services remain unknown until after you apply.

Clinical support structure

Embody documents unlimited provider visits and 24/7 clinical chat included in the medication price. PlexusDx includes unlimited messaging and scheduled visits. BetterMe Rx clinical support structure is not documented in available evidence; confirm what is included—and whether there are per-visit or per-contact fees—during your intake if you proceed.

Refund and satisfaction policies

Embody offers a 6-month satisfaction guarantee; PlexusDx does not offer a money-back guarantee. If a refund safety net is important to you, confirm the full terms of Embody's guarantee (eligibility, claim process, covered costs) before enrollment. BetterMe Rx refund policy is not documented; ask during intake if this matters to your decision.

Medication format and availability

As of July 2026 Embody's documented offerings are injection-only (semaglutide and tirzepatide). PlexusDx offers both injectable and oral/capsule formats for both medications. BetterMe Rx medication availability and formats are not documented; if you have a preference for oral therapy or need a specific compound, confirm availability during intake.

Choose Embody if…

  • You want published month-to-month pricing with no commitment ($299 semaglutide, $349 tirzepatide) and the flexibility to cancel anytime.
  • Unlimited provider visits and 24/7 clinical chat support are high priorities and you want them included at no extra charge.
  • A 6-month satisfaction guarantee reduces your financial risk and you are comfortable verifying the full terms before enrollment.
  • Injectable formats meet your needs and you do not require oral or capsule alternatives.

Choose BetterMe Rx if…

  • You are comfortable learning pricing, billing structure, clinical inclusions, and refund terms only after completing an intake questionnaire.
  • You prefer a provider that does not publish rates publicly, possibly because pricing is individualized or negotiated based on health profile.
  • You are willing to invest time in an application before knowing total cost or commitment requirements.

Important: Because BetterMe Rx commercial terms are not documented in public evidence, confirm during your intake: medication cost and billing cadence, any membership or per-visit fees, clinical support inclusions, cancellation policy, refund or guarantee terms, and medication formats available.

Where PlexusDx fits

PlexusDx publishes transparent month-to-month rates and prepaid totals for both injectable and oral GLP-1 medications. Semaglutide injection is $189 month-to-month, $169/month at the 3-month prepaid rate, or $149/month at the 6-month prepaid rate ($1,788 annual at the lowest rate, our calculation). Tirzepatide injection is $289 month-to-month, $269/month at 3-month, or $249/month at 6-month ($2,988 annual at the lowest rate, our calculation). Unlimited messaging and scheduled provider visits are included; there is no membership fee.

If the Embody month-to-month rate exceeds your budget and BetterMe Rx pricing remains unknown until intake, PlexusDx offers a third option with published rates that are lower than Embody's documented month-to-month prices for both semaglutide and tirzepatide injections. You also gain access to oral formats (semaglutide capsules $289 MTM, tirzepatide capsules $349 MTM) if injections are not your preference.

PlexusDx does not offer a money-back guarantee; if that feature is essential, Embody's 6-month satisfaction guarantee may better match your risk tolerance. If transparent published pricing, format choice, and lower documented cost matter more, PlexusDx may be a stronger fit.

Methodology and freshness

Embody pricing and program details were captured from the public website on July 21, 2026. BetterMe Rx website was captured July 20, 2026; the site states pricing is shown after questionnaire completion, and no checkout verification has been completed as of that date. PlexusDx rates are current as of publication (September 3, 2026).

We publish standard ongoing rates and prepaid totals only, verified at the dates shown. All 12-month cost calculations are ours, derived by multiplying documented monthly rates by 12 or summing documented prepaid period totals over 12 months. Where a competitor may offer lower committed-term rates, such figures are withheld per our rule that those rates never appear in our comparisons; we compare like billing structures (month-to-month vs. month-to-month, prepaid vs. prepaid where both exist).

All claims are limited to what the evidence supports as of the capture dates. If you find pricing, terms, or features that differ from what is reported here, that may reflect changes after our evidence dates, regional or eligibility-based variation, or details revealed only during intake. Confirm all costs, commitment requirements, clinical inclusions, and policies at checkout or during your provider consultation.

Frequently Asked Questions

Why is BetterMe Rx pricing not shown in this comparison?

BetterMe Rx discloses pricing only after completing an online questionnaire. As of July 20, 2026 no public pricing, medication formats, billing cadence, or clinical support details have been documented or verified through checkout. We report only what the evidence supports; speculating about undisclosed terms would violate our methodology.

Does Embody charge the same price at every dose?

Yes. Embody's website states the same monthly price applies regardless of dose for both semaglutide ($299) and tirzepatide ($349) injections, verified July 21, 2026. Your provider determines appropriate dosing; cost does not increase as dose is titrated.

What does Embody's 6-month satisfaction guarantee cover?

Embody advertises a 6-month satisfaction guarantee, but full terms—including eligibility criteria, claim process, and which costs are refunded—were not captured in our July 2026 evidence. Confirm the complete guarantee terms and any exclusions with Embody before enrollment if this feature influences your decision.

Can I get oral semaglutide or tirzepatide from Embody?

As of July 21, 2026 Embody's documented offerings are injectable semaglutide and tirzepatide only. Oral or capsule formats were not mentioned in captured materials. If you prefer non-injectable therapy, confirm availability directly with Embody or consider a provider that documents oral options, such as PlexusDx.

How do I learn BetterMe Rx pricing and terms?

Complete BetterMe Rx's online questionnaire; pricing and program details are shown after submission. Before proceeding, confirm: medication cost and billing cadence, any membership or per-visit fees, clinical support inclusions, cancellation policy, refund or guarantee terms, and available medication formats. Document the full terms so you can compare them to published-price alternatives.

Sources

  • Embody public website, pricing and program features, captured July 21, 2026
  • BetterMe Rx public website, pricing disclosure statement, captured July 20, 2026
  • PlexusDx published rates and program terms, current as of September 3, 2026

Ready to see if PlexusDx is right for you?

One all-inclusive price covers your online provider visit, prescription, medication, and shipping—no membership, no hidden fees. Complete a short intake and a licensed provider reviews your fit.

Start My Intake →

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.